Epigallocatechin-3-gallate alleviates-galactose-induced aging impairment via gut-brain communication

Qiong Wu,Yiping Luo,Xiaofang Tang,Yichi Zhang,Chen Su-Mei,Wenjuan Li
DOI: https://doi.org/10.1039/d2fo00994c
2022-09-28
Abstract:The study aimed to determine whether gut-brain communication could be modulated by Epigallocatechin-3-gallate (EGCG) in a mouse aging model that was established by daily injection of D-galactose (D-gal) for 10 weeks. Our results showed that EGCG could improve aging-associated changes by increasing immune organ indexes, brain index, learning and memory ability in vivo. EGCG-triggered aging prevention was associated with reduction of lipid peroxidation, and elevation of enzymatic and non-enzymatic antioxidant activities in the brain. Concomitantly, treatment of D-gal-induced aging mice with EGCG, significantly reduced corticotropin-releasing hormone, adrenocorticotropic hormone, and corticosterone, suggesting that EGCG-exerted protection of the aging brain was involved in inhibition of the hypothalamic-pituitary-adrenal (HPA) axis. Further data concerning intestinal function showed that EGCG could enhance fecal moisture in vitro, and reduce pH value in feces in aging mice when compared to D-gal group, suggesting that EGCG possessed beneficial roles in intestine of aging mice. Moreover, short-chain fatty acids (SCFAs), the mediators of gut-brain communication, were significantly strengthened in the intestinal contents of aging mice by the treatment of EGCG. Therefore, tea polyphenols EGCG performed-anti-aging capacities were demonstrated to be implicated in modulating gut-brain communication by attenuating the HPA axis and enhancing the content of SCFAs.
biochemistry & molecular biology,food science & technology
What problem does this paper attempt to address?